滚动资讯
Endpoints NewsPulmonary fibrosis biotech Avalyn Pharma files for IPOThermo FisherThermo Fisher Scientific stock: Steady growth amid biotech shifts – what investors need to know - AD HOC NEWSAgilentAgilent Technologies Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatchThermo FisherThermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatchFierceBiotechMedline hit with FDA warning letter over defective heart syringes, safety hazardsLonza NewsLonza Group AG stock: What investors need to know for long-term growth - AD HOC NEWSBioPharma DiveSidewinder secures $137M to advance ‘precision’ ADCsWatersWaters Corporation Receives FDA Clearance for At-Home HPV Self-Collection Kit - Healthcare PackagingAgilentHow New Diagnostic Win and Patent Loss Will Impact Agilent Technologies (A) Investors - simplywall.stEndpoints NewsPhRMA head Steve Ubl to step down at end of yearBioPharma DiveWith 3 quick buyouts, Gilead leans into its latest transformationFierceBiotechArtivion nabs PMA clearance for aortic stent graft system, triggers Endospan buyout option
Endpoints News 2026年4月9日

Pulmonary fibrosis biotech Avalyn Pharma files for IPO

Pulmonary fibrosis biotech Avalyn Pharma files for IPO

原文
暂时没有全文，请查看原始来源。

目录

59 全部